Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
FS Bancorp
FSBW
$316M
| $2.96M | ﹤0.01% |
103,038
+59,615
| +137% | +$1.77M |
|
|
RAD
3277
DELISTED
Rite Aid Corporation
RAD
| $2.96M | ﹤0.01% |
438,617
-1,514,109
| -78% | -$10M |
|
|
ATRI
3278
DELISTED
Atrion Corp
ATRI
| $2.95M | ﹤0.01% |
4,694
+900
| +24% | +$588K |
|
3279
Dr. Reddy's Laboratories
RDY
$10.1B
| $2.95M | ﹤0.01% |
266,220
-3,035,750
| -92% | -$33M |
|
3280
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.3B
| $2.95M | ﹤0.01% |
32,504
-212,603
| -87% | -$20.5M |
|
3281
Upstart Holdings
UPST
$2.94B
| $2.95M | ﹤0.01% |
93,243
-79,655
| -46% | -$4.74M |
|
3282
Halozyme
HALO
$11.6B
| $2.95M | ﹤0.01% |
66,984
+3,746
| +6% | +$162K |
|
3283
ChargePoint
CHPT
$158M
| $2.94M | ﹤0.01% |
10,749
+5,184
| +93% | +$1.44M |
|
3284
CALL
Veru
VERU
$44.5M
| $2.94M | ﹤0.01% |
+26,000
| New | +$3.02M |
|
|
AXNX
3285
CALL
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.94M | ﹤0.01% |
+51,800
| New | +$2.84M |
|
3286
CALL
Rivian
RIVN
$23.7B
| $2.93M | ﹤0.01% |
113,800
+103,800
| +1,038% | +$3.24M |
|
3287
Vera Bradley
VRA
$96.4M
| $2.93M | ﹤0.01% |
+674,230
| New | +$4.12M |
|
3288
CALL
Arcus Biosciences
RCUS
$3.66B
| $2.92M | ﹤0.01% |
115,300
-133,700
| -54% | -$3.27M |
|
3289
SunCoke Energy
SXC
$799M
| $2.92M | ﹤0.01% |
+428,892
| New | +$3.46M |
|
|
DISH
3290
CALL
DELISTED
DISH Network Corp.
DISH
| $2.92M | ﹤0.01% |
+162,700
| New | +$3.94M |
|
3291
WSFS Financial
WSFS
$4.12B
| $2.92M | ﹤0.01% |
+72,727
| New | +$2.99M |
|
3292
Biomea Fusion
BMEA
$92.1M
| $2.91M | ﹤0.01% |
+243,124
| New | +$1.42M |
|
|
ECOM
3293
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.9M | ﹤0.01% |
198,794
-283,275
| -59% | -$4.05M |
|
3294
Freshworks
FRSH
$3.31B
| $2.9M | ﹤0.01% |
220,115
-8,234
| -4% | -$128K |
|
3295
BlueLinx
BXC
$719M
| $2.89M | ﹤0.01% |
43,318
-128,357
| -75% | -$9.64M |
|
3296
Amneal Pharmaceuticals
AMRX
$5.71B
| $2.89M | ﹤0.01% |
908,279
+772,235
| +568% | +$2.8M |
|
|
QFTA
3297
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
| $2.89M | ﹤0.01% |
293,584
-102,723
| -26% | -$1.01M |
|
|
KCA.U
3298
DELISTED
Kensington Capital Acquisition Corp. IV New units, each consisting of one Class A ordinary share and one Class 2 redeemable warrant
KCA.U
| $2.88M | ﹤0.01% |
+300,000
| New | +$2.91M |
|
3299
CALL
NCR Voyix
VYX
$1.09B
| $2.88M | ﹤0.01% |
+150,938
| New | +$3.22M |
|
3300
Mattel
MAT
$4.21B
| $2.87M | ﹤0.01% |
128,664
-756,085
| -85% | -$17.9M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.